Monday, December 6, 2010

Keeping You in the Loop: Triglyceride Trial Follow Up

Amarin Pharmaceutical's Omega-3 medication that was studied in the PMG network this year was found to lower triglyceride levels by 45% in study participants.

Triglycerides are a type of fat that can lead to heart disease when found in high levels in the blood.  More than 3.8 million people in the US have high triglyceride levels.  Similar medications have been found to raise bad cholesterol, or LDL, by as much as 40-50%, but Amarin's medication did not cause an increase in bad cholesterol.  Amarin hopes to submit it's triglyceride medication to the FDA for review sometime next year.  Thank you to all of the volunteers that participated in these trials with us in Mt. Pleasant, Winston-Salem, Raleigh and Hickory!


No comments :

Post a Comment

Subscribe Via Email